Some of the stocks that may grab investor focus today are:
Wall Street expects Mastercard Inc (NYSE: MA) to report quarterly earnings at $1.72 per share on revenue of $4.34 billion before the opening bell. Mastercard shares fell 0.2% to $382.88 in after-hours trading.
A South Korean study, mixed vaccination of first AstraZeneca plc’s (NASDAQ:AZN) jab followed by the Pfizer Inc (NYSE:PFE) – BioNTech SE (NASDAQ:BNTX) shot boosted…
AstraZeneca Plc (NASDAQ: AZN) said that the European Medicines Agency (EMA) has recommended approving a medicine from its recently acquired Alexion for a rare, deadly blood disorder in children and adolescents aged up to 18 years.
Alexion's Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for expanded use to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH).
Much focus on investment comes from the private sector, particularly those of the venture capitalist persuasion. But one of the biggest investors this country has is the federal government.